 |
Quick Links |
| Information by Disease |
|
|
|
| Cancer News |
|
|
|
| Conference Coverage |
|
|
|
| AZN | $44.82 | -0.37 (-0.82%)
| | NVS | $53.13 | -0.16 (-0.3%)
| | SNY | $37.67 | -0.01 (-0.03%)
| | GSK | $41.53 | 0.06 (0.14%)
|
|
|
|
Lung Cancer - General
|
|
High Time Costs for Informal Care Givers of Cancer Patients (9/10/2009)
Researchers from the National Cancer Institute (NCI) have reported that the time spent by informal caregivers is significant and an important component in the overall burden of cancer care. The details of this study appeared in the September 4, 2009 issue of Cancer.
Bilateral Oophorectomy Increases Risk of Lung Cancer (7/30/2009)
Researchers from Canada have reported that women who have bilateral oophorectomy are 1.92 times as likely to develop lung cancer as women who have natural menopause. The details of this study appeared in an early on-line publication in the International Journal of Cancer on May 11, 2009.
Smoking Kills More Than 440,000 People Each Year in the United States (4/27/2009)
According to an analysis by the U.S. Centers for Disease Control and Prevention (CDC), cigarette smoking and exposure to tobacco smoke cause at least 443,000 premature deaths each year in the United States alone. These results, based on data from 2000-2004, were published in the Morbidity and Mortality Weekly Report.
Little Evidence That Lycopene Reduces Cancer Risk (7/23/2007)
According to a review conducted by the U.S. Food and Drug Administration (FDA), there is “no credible evidence” that lycopene reduces the risk of cancers such as prostate cancer, and “very limited evidence” that tomato consumption reduces risk. The review was published in the July 10,2007 issue of the Journal of the National Cancer Institute.
NDA Accepted for Xcytrin (5/7/2007)
The United States Food and Drug Administration (FDA) has accepted the new drug application (NDA) submitted for Pharmacyclics’ new agent Xcytrin (motexafin gadolinium). Pharmacyclics is seeking approval for the use of Xcytrin in combination with radiation therapy for the treatment of patients with non-small cell lung cancer (NSCLC) and brain metastases.
Response Rate to Chemotherapy for NSCLC not Affected by Ethyol® (5/2/2007)
Researchers from the MD Anderson Cancer Center have reported that response rates for locally advanced non-small-cell lung cancer (NSCLC) to chemotherapy are not affected by Ethyol® (amifostine) cytoprotection. The details of this study appeared in an early on-line publication in the International Journal of RadiationOncology* Biology* Physics on February 6, 2007.
Radiotherapy May be Best Choice for Selected Patients with Stage IIIA NSCLC (3/26/2007)
Researchers affiliated with the European Organisation for Research and Treatment of Cancer (EORTC)-Lung Cancer Group have reported that patients with stage IIIA-N2 non-small-cell lung cancer (NSCLC) who respond to chemotherapy have equivalent survivals following radiotherapy or surgery. The details of this study appeared in the March 21, 2007 issue of the Journal of the National Cancer Institute.
Workplace Exposure to Second-Hand Tobacco Smoke Associated with Increased Lung Cancer Risk (3/15/2007)
An international multi-center study has confirmed that exposure to second-hand tobacco smoke increases the risk of developing lung cancer. The details of this study appeared in the March 1, 2007 issue of the American Journal of Public Health.
Further Data Links Family History of Lung Cancer to Increased Risk of Cancers Among Never-Smokers (2/28/2007)
Researchers from the M.D. Anderson Cancer Center have reported that a family history of lung cancer significantly increases risk of developing lung and other cancers in non-smokers.
Non-Smoking Women at Higher Risk of Lung Cancer Than Non-Smoking Men (2/14/2007)
An international group has reported that women who have never smoked are at a higher risk of developing lung cancer than men who have never smoked.
Monitoring Bronchial Dysplasia Results in Early Diagnosis of Lung Cancer (2/1/2007)
Researchers from the United Kingdom have reported that patients with bronchial dysplasia may have improved chances of a cure if they are regularly screened and monitored for the development of lung cancer.
Special Protocol Assessment Filed for Xyotax (2/1/2007)
Cell Therapeutics has filed with the United States Food and Drug Administration (FDA) for a special protocol assessment (SPA) for the design of a phase III trial evaluating their investigative agent Xyotax.
Calypso® 4D Localization System May Improve Efficacy of External Beam Radiotherapy (12/1/2006)
At the 2006 meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in November there were 10 abstracts presented that describe a new system for measuring and monitoring organ motion in real time during external beam radiotherapy (EBRT).
Further Data Indicates Hereditary Link to Lung Cancer (11/20/2006)
Researchers from the United Kingdom have reported that individuals who have family members diagnosed with lung cancer, particularly those whose family members were diagnosed at an early age, are at a significantly increased risk of developing lung cancer themselves.
Surgical Removal May Improve Survival for All Stages of Lung Cancer (8/10/2006)
Researchers from Norway have reported that surgical removal of lung cancer may improve outcomes of patients with lung cancer, including those with locally advanced or metastatic disease.
Women May Have Increased Susceptibility to Tobacco Carcinogens Compared to Men (7/12/2006)
Researchers affiliated with the International Early Lung Cancer Action Program have reported that women may have increased susceptibility to tobacco carcinogens but have a better survival after the diagnosis of lung cancer when compared to men.
Primary Care Physicians Tend to Not Understand Role of Chemotherapy in Lung Cancer Patients (6/5/2006)
Only 11% of primary care physicians believe that patients with early-stage lung cancer can achieve benefit from treatment with chemotherapy, resulting in potentially suboptimal referral rates of these patients to oncologists. These results were recently reported at the 2006 annual meeting of the American Society of Clinical Oncology (ASCO).
Risk Factors for Non-Smoking Related Lung Cancer Reported (5/22/2006)
Researchers from M.D. Anderson Cancer Center have reported that exposure to second-hand tobacco smoke, dusts and family history of early cancer is associated with an increased risk of non-smoking related lung cancer. Researchers from the same institution have also reported that first-degree relatives of lung cancer patients who have never smoked are at an increase risk of developing any cancer.
No Increase in Lung Cancer in Non-Smokers in Past 40 Years (5/22/2006)
Researchers from the American Cancer Society and the University of California at San Diego have reported that the incidence of lung cancer in non-smokers has remained relatively constant at approximately 15 per 100,000 for men and 12 per 100,000 for women since 1959.
Epoetin Alfa May Improve Survival After Chemoradiotherapy for Esophageal Cancer (5/10/2006)
Researchers from Germany have reported a follow-up study of a previous trial showing that the administration of epoetin alfa to maintain hemoglobin levels between 12 and 14 g/dL improves overall survival and locoregional control of stage III esophageal cancer receiving chemotherapy and radiation therapy.
Tomudex® Plus Platinol® and Platinol Alone Therapies Both Reduce Dyspnea in Patients With Mesothelioma (3/22/2006)
Researchers affiliated with the European Organization for Research and Treatment of Cancer (EORTC) Lung Cancer Group and the National Cancer Institute of Canada have reported that the combination of Tomudex (raltitrexed) and Platinol® (cisplatin) or Platinol alone decrease dyspnea in patients with malignant pleural mesothelioma (MPM).
Lung Cancer Incidence in Smokers Varies Across Ethnic Groups (2/2/2006)
Researchers from the University of Southern California and the University of Hawaii have reported that African Americans and Native Hawaiians appear to be more susceptible to developing smoking induced lung cancer than whites, Japanese Americans, and Latinos.
Anemia in Lung Cancer Patients Often Undertreated (11/30/2005)
Researchers affiliated with the European Cancer Anaemia Survey (ECAS) have reported that approximately 50% of patients with lung cancer with anemia received appropriate treatment.
Smoking Reduction Reduces Lung Cancer Risk (9/29/2005)
Researchers from Denmark have reported that individuals who smoke 15 or more cigarettes per day can lower their risk of lung cancer by 25% by reducing the number of cigarettes smoked by 50%.
Quality of Life of Long-Term Lung Cancer Survivors Evaluated (7/12/2005)
Researchers from the Mayo Clinic have reported that the quality of life of long-term survivors of lung cancer shows measurable deficits and decline over time.
Family History of Early Onset Lung Cancer Increases Risk of Lung Cancer Especially in Blacks (6/23/2005)
Researchers from Karmanos Cancer Institute have reported that first-degree relatives of patients with early onset lung cancer have an increased risk of smoking induced lung cancer that is greater in black individuals than in white individuals.
CT Scans plus PET Scans Detect Early Lung Cancer in Heavy Smokers (8/26/2003)
Italian researchers have reported that PET scans can help distinguish benign from malignant lesions detected on annual CT screening for lung cancer in heavy smokers. These results were published in the August 23, 2003 issue of the
Lancet.
Non-Steroidal Anti-Inflammatory Agents May Reduce Incidence of Lung Cancer in Smokers and Ex-Smokers (5/12/2003)
Researchers from Several New York Medical Centers have reported that the risk of lung cancer in smokers can be lowered by the use of non-steroidal anti-inflammatory agents NSAIDs. The reported these findings in the March 18, 2003 issue of
Cancer.
|
|
Patient Home
